| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 2005;130:416-425
© 2005 The American Association for Thoracic Surgery
General Thoracic Surgery |
a Department of Thoracic Surgery, Université de la Méditerranée (Aix-Marseille II), Faculty of Medicine, Sainte-Marguerite Hospital, Assistance Publique-Hôpitaux de Marseille, Marseille, France
b Department of Oncology, Université de la Méditerranée (Aix-Marseille II), Faculty of Medicine, Sainte-Marguerite Hospital, Assistance Publique-Hôpitaux de Marseille, Marseille, France
c Department of Medical Information & Biostatistics, Université de la Méditerranée (Aix-Marseille II), Faculty of Medicine, Sainte-Marguerite Hospital, Assistance Publique-Hôpitaux de Marseille, Marseille, France
d UPRES EA 2201, IFR Jean Roche, Marseille, France.
Received for publication September 3, 2004; revisions received October 27, 2004; accepted for publication November 23, 2004. * Address for reprints: Christophe Doddoli, MD, Service de Chirurgie Thoracique, Hôpital Sainte-Marguerite, 270, Bd de Sainte-Marguerite, 13274 Marseille Cedex 09, France. (Email: christophe.doddoli{at}mail.ap-hm.fr).
OBJECTIVE: We sought to assess postoperative outcome after pneumonectomy after neoadjuvant therapy in patients with non-small cell lung cancer.
METHODS: This retrospective study included 100 patients treated from January 1989 through December 2003 for a primary lung cancer in whom pneumonectomy had been performed after an induction treatment. Surgical intervention had not been considered initially for the following reasons: N2 disease (stage IIIA, n = 79), doubtful resectability (stage IIIB [T4, N0], n = 19), and M1 disease (stage IV [T2, N0, M1, solitary brain metastasis], n = 2). All patients received a 2-drug platinum-based regimen with a median of 2.5 cycles (range, 2–4 cycles), and 30 had associated radiotherapy (30–45 Gy).
RESULTS: There were 55 right and 45 left resections. Overall 30-day and 90-day mortality rates were 12% and 21%, respectively. At multivariate analysis, one inde- pendent prognostic factor entered the model to predict 30-day mortality: postoperative cardiovascular event (relative risk, 45.7; 95% confidence interval, 3.7–226.7; P = .001). Four variables predicted 90-day mortality: age of more than 60 years (relative risk, 5.06; 95% confidence interval, 1.47–17.48; P = .01), male sex (relative risk, 8.25; 95% confidence interval, 1.01–67.34; P = .049), postoperative respiratory event (relative risk, 3.64; 95% confidence interval, 1.14–9.37; P = .007), and postoperative cardiovascular event (relative risk, 7.84; 95% confidence interval, 3.12–19.71; P < .001). Estimated overall survivals in 90-day survivors were 35% (range, 29%-41%) and 25% (range, 19.3%-30.7%) at 3 and 5 years, respectively. At multivariate analysis, one independent prognostic factor entered the model: pathologic stage III-IV residual disease (relative risk, 1.89; 95% confidence interval, 1.09–3.26; P = .022).
CONCLUSIONS: Pneumonectomy after induction therapy is a high-risk procedure, the survival benefit of which appears uncertain.
This article has been cited by other articles:
|
|
 |
|
  P. A. Thomas Pneumonectomy following induction therapy: an evidence-based, experienced-based and eloquence-based point of view Eur J Cardiothorac Surg, February 13, 2012; (2012) ezs035v1. [Full Text] [PDF]
|
|
|
|
|
|
V. Steger, W. Spengler, J. Hetzel, S. Veit, T. Walker, M. Mustafi, G. Friedel, and T. Walles Pneumonectomy: calculable or non-tolerable risk factor in trimodal therapy for Stage III non-small-cell lung cancer? Eur J Cardiothorac Surg, January 10, 2012; (2012) ezr160v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Kim, D. J. Boffa, Z. Wang, and F. C. Detterbeck An analysis, systematic review, and meta-analysis of the perioperative mortality after neoadjuvant therapy and pneumonectomy for non-small cell lung cancer J. Thorac. Cardiovasc. Surg., January 1, 2012; 143(1): 55 - 63. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. B. D'Journo, J. M. Rolain, C. Doddoli, D. Raoult, and P. A. Thomas Airways colonizations in patients undergoing lung cancer surgery Eur J Cardiothorac Surg, August 1, 2011; 40(2): 309 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Martinod, D. M. Radu, K. Chouahnia, A. Seguin, A. Fialaire-Legendre, P.-Y. Brillet, M.-D. Destable, G. Sebbane, S. Beloucif, D. Valeyre, et al. Human Transplantation of a Biologic Airway Substitute in Conservative Lung Cancer Surgery Ann. Thorac. Surg., March 1, 2011; 91(3): 837 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Shapiro, S. J. Swanson, C. D. Wright, C. Chin, S. Sheng, J. Wisnivesky, and T. S. Weiser Predictors of Major Morbidity and Mortality After Pneumonectomy Utilizing The Society for Thoracic Surgeons General Thoracic Surgery Database Ann. Thorac. Surg., September 1, 2010; 90(3): 927 - 935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Stefani, M. Alifano, A. Bobbio, M. Grigoroiu, R. Jouni, P. Magdeleinat, and J.-F. Regnard Which patients should be operated on after induction chemotherapy for N2 non-small cell lung cancer? Analysis of a 7-year experience in 175 patients J. Thorac. Cardiovasc. Surg., August 1, 2010; 140(2): 356 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Radu, A. Seguin, P. Bruneval, A. Fialaire Legendre, A. Carpentier, and E. Martinod Bronchial Replacement With Arterial Allografts Ann. Thorac. Surg., July 1, 2010; 90(1): 252 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Amar, D. Munoz, W. Shi, H. Zhang, and H. T. Thaler A Clinical Prediction Rule for Pulmonary Complications After Thoracic Surgery for Primary Lung Cancer Anesth. Analg., May 1, 2010; 110(5): 1343 - 1348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. Evans III, S. Li, C. D. Wright, M. S. Allen, and H. A. Gaissert The impact of induction therapy on morbidity and operative mortality after resection of primary lung cancer. J. Thorac. Cardiovasc. Surg., April 1, 2010; 139(4): 991 - 996.e2. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hampel, I. Dally, T. Walles, V. Steger, S. Veit, T. Kyriss, and G. Friedel Impact of neo-adjuvant radiochemotherapy on bronchial tissue viability Eur J Cardiothorac Surg, February 1, 2010; 37(2): 461 - 466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Leo, P. Scanagatta, F. Vannucci, D. Brambilla, D. Radice, and L. Spaggiari Impaired quality of life after pneumonectomy: Who is at risk? J. Thorac. Cardiovasc. Surg., January 1, 2010; 139(1): 49 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Krasna, Z. Gamliel, W. M. Burrows, J. R. Sonett, K. F. Kwong, M. J. Edelman, P. F. Hausner, L. A. Doyle, C. DeYoung, and M. Suntharalingam Pneumonectomy for Lung Cancer After Preoperative Concurrent Chemotherapy and High-Dose Radiation Ann. Thorac. Surg., January 1, 2010; 89(1): 200 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Kim, L. P. Faber, W. H. Warren, S. Basu, S. C. Wightman, J. A. Weber, P. Bonomi, and M. J. Liptay Pneumonectomy After Chemoradiation Therapy for Non-Small Cell Lung Cancer: Does "Side" Really Matter? Ann. Thorac. Surg., September 1, 2009; 88(3): 937 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Gaissert, D. Y. Keum, C. D. Wright, M. Ancukiewicz, E. Monroe, D. M. Donahue, J. C. Wain, M. Lanuti, J. S. Allan, N. C. Choi, et al. POINT: Operative risk of pneumonectomy--influence of preoperative induction therapy. J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 289 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Gudbjartsson, E. Gyllstedt, A. Pikwer, and P. Jonsson Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Ann. Thorac. Surg., August 1, 2008; 86(2): 376 - 382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Mansour, E. A. Kochetkova, N. Santelmo, X. Ducrocq, E. Quoix, J.-M. Wihlm, and G. Massard Persistent N2 Disease After Induction Therapy Does Not Jeopardize Early and Medium Term Outcomes of Pneumonectomy Ann. Thorac. Surg., July 1, 2008; 86(1): 228 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Alifano, M. S. Boudaya, M. Salvi, J.-Y. Collet, C. Dinu, S. Camilleri-Broet, and J.-F. Regnard Pneumonectomy After Chemotherapy: Morbidity, Mortality, and Long-Term Outcome Ann. Thorac. Surg., June 1, 2008; 85(6): 1866 - 1873. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Breen and F. Barlesi The place of excision repair cross complementation 1 (ERCC1) in surgically treated non-small cell lung cancer Eur J Cardiothorac Surg, May 1, 2008; 33(5): 805 - 811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Pourel, N. Santelmo, N. Naafa, A. Serre, W. Hilgers, L. Mineur, N. Molinari, and F. Reboul Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response Eur J Cardiothorac Surg, May 1, 2008; 33(5): 829 - 836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Uy, G. Darling, W. Xu, Q.-L. Yi, M. De Perrot, A. F. Pierre, T. K. Waddell, M. R. Johnston, A. Bezjak, F. A. Shepherd, et al. Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 188 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Trousse, F. Barlesi, A. Loundou, A. M. Tasei, C. Doddoli, R. Giudicelli, P. Astoul, P. Fuentes, and P. Thomas Synchronous multiple primary lung cancer: An increasing clinical occurrence requiring multidisciplinary management J. Thorac. Cardiovasc. Surg., May 1, 2007; 133(5): 1193 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Mansour, E. A. Kochetkova, X. Ducrocq, M.-D. Vasilescu, G. Maxant, A. Buggenhout, J.-M. Wihlm, and G. Massard Induction chemotherapy does not increase the operative risk of pneumonectomy! Eur J Cardiothorac Surg, February 1, 2007; 31(2): 181 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D.T. Daly, H. C. Fernando, A. Ketchedjian, T. A. DiPetrillo, L. A. Kachnic, D. M. Morelli, and R. J. Shemin Pneumonectomy After High-Dose Radiation and Concurrent Chemotherapy for Nonsmall Cell Lung Cancer Ann. Thorac. Surg., July 1, 2006; 82(1): 227 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-i. Takeda Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer Eur J Cardiothorac Surg, July 1, 2006; 30(1): 184 - 189. [Full Text] [PDF]
|
|
|
|
|
|
R. J. Battafarano Optimal management of patients with non-small cell lung cancer with ipsilateral mediastinal lymph node metastases J. Thorac. Cardiovasc. Surg., June 1, 2006; 131(6): 1227 - 1228. [Full Text] [PDF]
|
|
|
|
|
|
J. L. Freixinet, G. Julia-Serda, P. M. Rodriguez, N. B. Santana, F. R. de Castro, M. D. Fiuza, A. Lopez-Encuentra, and Bronchogenic Carcinoma Cooperative Group of the Sp Hospital volume: operative morbidity, mortality and survival in thoracotomy for lung cancer: A Spanish multicenter study of 2994 cases Eur J Cardiothorac Surg, January 1, 2006; 29(1): 20 - 25. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
